Product Name: Nifedipine |
 |
Appearance: Yellow Crystalline Powder |
 |
CAS: 21829-25-4 |
 |
Product Name: Nifedipine Synonyms: 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylicaciddime 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester 4-(2¡¯-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethy 5-pyridinedicarboxylicacid,1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-dim Adalat CC bay1040 corinfar Dimethyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate CAS: 21829-25-4 MF: C17H18N2O6 MW: 346.34 EINECS: 244-598-3 Assay: 99% Package: 25kg/carton Appearance: Yellow Crystalline Powder Usage Used as an antihypertensive and antianginal. A dihydorpyridine calcium channel blocker.
Others: Cardiovascular Agents: Minoxidil Metformin Metformin HCL Phenformine HCL Glybenzcyclamide Naphazoline HCl Mannitol Hydrochlorothiazide Dextran 20/40/70 Tranexamic acid Clonidine hydrochloride Nifedipine Ms. Julia ycgc_int04@yccreate.com
|
 |
Product Name: Nifedipine Synonyms: 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylicaciddime 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester 4-(2¡¯-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethy 5-pyridinedicarboxylicacid,1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-dim Adalat CC bay1040 corinfar Dimethyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate CAS: 21829-25-4 MF: C17H18N2O6 MW: 346.34 EINECS: 244-598-3 Assay: 99% Package: 25kg/carton Appearance: Yellow Crystalline Powder Usage Used as an antihypertensive and antianginal. A dihydorpyridine calcium channel blocker.
Others: Cardiovascular Agents: Minoxidil Metformin Metformin HCL Phenformine HCL Glybenzcyclamide Naphazoline HCl Mannitol Hydrochlorothiazide Dextran 20/40/70 Tranexamic acid Clonidine hydrochloride Nifedipine Ms. Julia ycgc_int04@yccreate.com
|
Á¦Ç°°ü·ÃºÐ¾ß |
÷°¡Á¦, ÀǾà,Áß°£Ã¼ |
|
|
 |
|
|
|
 |
ÀÌÁ¦Ç°¿¡ ´ëÇØ µî·ÏµÈ ÆÇ¸Å¾÷ü°¡ ¾ø½À´Ï´Ù. |
|
 |
|
|